Reporting owner · CIK 0001662982
Wang Xiaodong
SEC Form 4 history across 1 companies, 29 transactions and 3 filings.
DIRBeOne Medicines Ltd.
Open-market transaction mix0% buys0 buys · 23 sales
Available history · Sep 08, 2026 – Oct 13, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$445kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$2.31MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.99MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$3.63MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$2.50MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedSEC filing ↗ | $1.14MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$271kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$5.32MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$748kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.24MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.27MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.53MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$809kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$14.3kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$43.0kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$57.1kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedSEC filing ↗ | $1.14MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at BeOne Medicines Ltd. on Oct 13, 2026 valued at $445,078.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 2 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Sep 2026 | 0 | 18 | $0.00 | $24,684,649.72 | -$24,684,649.72 |
| Oct 2026 | 0 | 5 | $0.00 | $10,890,073.93 | -$10,890,073.93 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$1.5M
Median P/S size$1.2M
Direct29
Indirect0
Oct 13, 2026exercise
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
26 observations · Sep 8, 2026 – Oct 13, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 13, 20260 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Sep 8, 2026 | 6,079 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 3,238 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 1,721 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 0 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 31,027 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 23,535 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 12,847 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 6,278 | Sep 10, 2026 | View transaction |
| Sep 8, 2026 | 0 | Sep 10, 2026 | View transaction |
| Sep 28, 2026 | 31,028 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 30,868 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 30,748 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 30,708 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 28,467 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 24,228 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 20,729 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 17,310 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 15,263 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 738 | Sep 30, 2026 | View transaction |
| Sep 28, 2026 | 0 | Sep 30, 2026 | View transaction |
| Oct 13, 2026 | 31,027 | Oct 15, 2026 | View transaction |
| Oct 13, 2026 | 23,860 | Oct 15, 2026 | View transaction |
| Oct 13, 2026 | 13,499 | Oct 15, 2026 | View transaction |
| Oct 13, 2026 | 7,818 | Oct 15, 2026 | View transaction |
| Oct 13, 2026 | 1,260 | Oct 15, 2026 | View transaction |
| Oct 13, 2026 | 0 | Oct 15, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Wang Xiaodong Insider Activity FAQ
SEC Form 4 context
Who is Wang Xiaodong?
Wang Xiaodong is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001662982.
Which companies has Wang Xiaodong reported transactions for?
BeOne Medicines Ltd., BeiGene, Ltd.
When was Wang Xiaodong's latest insider buy?
No open-market insider purchase is available for this period.
When was Wang Xiaodong's latest insider sale?
sale at BeOne Medicines Ltd. on Oct 13, 2026 valued at $445,078.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.